NCT03853824

Brief Summary

An international, multicentre, African cluster randomised trial. Primary objective : To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces overall in-hospital mortality in surgical patients aged 18 years and over in Africa. Primary outcome measure: In-hospital mortality, censored at 30 days if the patient is still alive and in-hospital. Secondary objective: To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces the overall incidence of the composite of severe in-hospital complications and mortality in adult surgical patients aged 18 years and over in Africa. Secondary outcome measure: Composite of severe in-hospital complications and mortality, censored at 30 days if the patient is still alive and in-hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27,507

participants targeted

Target at P75+ for not_applicable surgery

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

May 6, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

September 10, 2020

Status Verified

September 1, 2020

Enrollment Period

1.3 years

First QC Date

February 20, 2019

Last Update Submit

September 8, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • In hospital mortality.

    Number of Participants with In hospital mortality

    In-hospital, and censored at 30 days after surgery if still in-hospital.

Secondary Outcomes (1)

  • Composite of severe in-hospital complications and mortality

    In-hospital, and censored at 30 days after surgery if still in-hospital.

Other Outcomes (7)

  • In-hospital severe superficial or deep surgical site, or body cavity infection

    In-hospital, and censored at 30 days after surgery if still in-hospital.

  • In-hospital severe urinary tract or acute kidney injury

    In-hospital, and censored at 30 days after surgery if still in-hospital.

  • In-hospital severe bloodstream infection or acute respiratory distress syndrome

    In-hospital, and censored at 30 days after surgery if still in-hospital.

  • +4 more other outcomes

Study Arms (2)

Intervention arm

OTHER

Patients randomised to increased postoperative surveillance.

Other: Increased postoperative surveillance

Control arm

OTHER

Patients randomised to usual postoperative care.

Other: Usual postoperative care

Interventions

Increased postoperative surveillance can include either of the following; i) admission to a higher care ward than had been planned at the time of surgery, ii) an increase in the frequency of nursing observations in the postoperative period, iii) ensuring that the patient is placed in view of the nursing station, and not in a remote location in the postoperative ward, or iv) allowing family members to stay with the patient in the ward in the postoperative period.

Intervention arm

Participating sites randomised to the control arm will provide usual postoperative care to patients. The care will be left to the discretion of the healthcare providers.

Control arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All consecutive adult patients aged 18 years and over admitted to participating centres undergoing elective and non-elective surgery

You may not qualify if:

  • Prior participation in ASOS-2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groote Schuur Hospital

Cape Town, Western Cape, 8001, South Africa

Location

Related Publications (3)

  • Biccard BM, Madiba TE, Kluyts HL, Munlemvo DM, Madzimbamuto FD, Basenero A, Gordon CS, Youssouf C, Rakotoarison SR, Gobin V, Samateh AL, Sani CM, Omigbodun AO, Amanor-Boadu SD, Tumukunde JT, Esterhuizen TM, Manach YL, Forget P, Elkhogia AM, Mehyaoui RM, Zoumeno E, Ndayisaba G, Ndasi H, Ndonga AKN, Ngumi ZWW, Patel UP, Ashebir DZ, Antwi-Kusi AAK, Mbwele B, Sama HD, Elfiky M, Fawzy MA, Pearse RM; African Surgical Outcomes Study (ASOS) investigators. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet. 2018 Apr 21;391(10130):1589-1598. doi: 10.1016/S0140-6736(18)30001-1. Epub 2018 Jan 3.

    PMID: 29306587BACKGROUND
  • Vickery N, Stephens T, du Toit L, van Straaten D, Pearse R, Torborg A, Rolt L, Puchert M, Martin G, Biccard B; ASOS-2 Investigators. Understanding the performance of a pan-African intervention to reduce postoperative mortality: a mixed-methods process evaluation of the ASOS-2 trial. Br J Anaesth. 2021 Nov;127(5):778-788. doi: 10.1016/j.bja.2021.07.001. Epub 2021 Aug 24.

  • ASOS-2 Investigators. Enhanced postoperative surveillance versus standard of care to reduce mortality among adult surgical patients in Africa (ASOS-2): a cluster-randomised controlled trial. Lancet Glob Health. 2021 Oct;9(10):e1391-e1401. doi: 10.1016/S2214-109X(21)00291-6. Epub 2021 Aug 19.

Study Officials

  • Bruce M Biccard, MD, PhD

    University of Cape Town

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participating sites will be randomised to normal postoperative care, or increased postoperative surveillance. Randomisation will be stratified according to the level of the surgical facility and the expected weekly surgical case-load. Participating sites which have been randomised to increased surveillance will need to provide increased surveillance to surgical patients with a predicted increased postoperative risk as determined by the ASOS risk stratification tool. Participating sites randomised to the control arm will provide usual postoperative care to patients. The care will be left to the discretion of the healthcare providers.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Anaesthetist

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 26, 2019

Study Start

May 6, 2019

Primary Completion

August 31, 2020

Study Completion

August 31, 2020

Last Updated

September 10, 2020

Record last verified: 2020-09

Locations